unisa logo

UniSA CRI Board & Advisory Group

The UniSA CRI Board guides and provides advice on strategic matters including the effective management of the Institute, and its contribution to the University’s strategic research objectives. The Board membership consists of representatives from across UniSA including:

  • Deputy Vice Chancellor: Research and Enterprise (Chair)
  • Director: University of South Australia Cancer Research Institute 
  • Dean: Graduate Studies
  • Dean: Industry and Enterprise
  • Deans of Research: Clinical and Health Sciences Unit and Allied Health and Human Performance Unit
  • UniSA CRI Centre Directors: Centre for Cancer Diagnostics and Therapeutics, Australian Centre for Precision Health, Centre for Translational Cancer Research 
  • UniSA Ventures representative
  • Chief Financial Officer
  • Director of Advancement 
  • Pro Vice Chancellor: Aboriginal Leadership and Strategy 
  • Director: Research and Innovation Services 

The UniSA CRI Advisory Group provides expert advice and guidance to UniSA CRI and the University on the Institute’s strategic direction and future strategic opportunities for partnership and impact. The current membership is:

  • Professor Ian Caterson AM, Chair, Boden Professor of Human Nutrition, Director: Boden Collaboration, Charles Perkins Centre, The University of Sydney, Director: Charles Perkins Centre Royal Prince Alfred Clinic, Deputy Clinical Stream Director: Aged Health, Chronic Care, Andrology & Disability, Ambulatory, General Medicine, Endocrinology & Rehabilitation, SLHD
  • Professor Jim Bishop AO, former Executive Director, Victorian Comprehensive Cancer Centre, Herman Chair of Cancer Medicine, University of Melbourne
  • Professor Jennifer Martin, Chair of Clinical Pharmacology, School of Medicine and Public Health, The University of Newcastle, Senior Staff Specialist Internal Medicine at the Hunter New England Health District and Member of the NSW Council of the Australian Institute of Company Directors.
  • Professor Marnie Hughes-Warrington, Deputy Vice-Chancellor: Research & Enterprise, UniSA
  • Professor Alan Boddy, Director: UniSA Cancer Research Institute
  • Mr David Walsh, Woolmore Walsh Real Estate
  • Professor Anna deFazio, Sydney West Chair of Translational Cancer Research, The University of Sydney, Co-Director: Centre for Cancer Research, The Westmead Institute for Medical Research
  • Ms Kellie La Fontaine, Institute Manager: Cancer Research Institute, UniSA (Executive Officer)